1. Dai DW, Zhao WY, Zhang YW, Yang ZG, Li Q, Xu B et al. Role of CT perfusion imaging in evaluating the effects of multiple burr hole surgery on adult ischemic Moyamoya disease. Neuroradiology. 2013;55:1431-8.
2. Funaki T, Takahashi JC, Takagi Y, Yoshida K, Araki Y, Kikuchi T et al. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. J Neurosurg Pediatr. 2013;12:626-32.
3. Smith JL. Understanding and treating moyamoya disease in children Neurosurg Focus. 2009;26:34.
4. Bohannon RW, Smith MB. Interrater reliability of a modified ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-7.
5. Linder-Lucht M, Othmer V, Walther M, Vry J, Michaelis U, Stein S et al. Validation of the gross motor function measure for use in children and adolescents with traumatic brain injuries. Pediatrics. 2007;120:880-6.
6. Hertza J, Loughan A, Perna R, Davis AS, Segraves K, Tiberi NL. Moyamoya disease: a review of the literature. Appl Neuropsychol Adult. 2014;21:21-7.
7. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P et al. Perioperative complications and long-term outcomes after bypasses in adults withmoyamoya disease: a systematic review and meta-analysis. World Neurosurg. 2016;92:179-88.
8. Nam KS. Long-term outcome of motor function in a child with Moyamoya disease: a case report. J Phys Ther Sci. 2013;25:1647-9.
9. Coleman C, Marcantuono N. Moyamoya Disease and acute inpatient rehabilitation in a 17-month old previously healthy male. 2015. CWiC-PH, poster 37. http://jdc.jefferson.edu/ph/37.
10. Papavasiliou AS. Management of motor problems in cerebral palsy: a critical update for the clinician. Eur J Paediatr Neurol. 2009;13:387-96.
1. Dai DW, Zhao WY, Zhang YW, Yang ZG, Li Q, Xu B et al. Role of CT perfusion imaging in evaluating the effects of multiple burr hole surgery on adult ischemic Moyamoya disease. Neuroradiology. 2013;55:1431-8.
2. Funaki T, Takahashi JC, Takagi Y, Yoshida K, Araki Y, Kikuchi T et al. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. J Neurosurg Pediatr. 2013;12:626-32.
3. Smith JL. Understanding and treating moyamoya disease in children Neurosurg Focus. 2009;26:34.
4. Bohannon RW, Smith MB. Interrater reliability of a modified ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-7.
5. Linder-Lucht M, Othmer V, Walther M, Vry J, Michaelis U, Stein S et al. Validation of the gross motor function measure for use in children and adolescents with traumatic brain injuries. Pediatrics. 2007;120:880-6.
6. Hertza J, Loughan A, Perna R, Davis AS, Segraves K, Tiberi NL. Moyamoya disease: a review of the literature. Appl Neuropsychol Adult. 2014;21:21-7.
7. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P et al. Perioperative complications and long-term outcomes after bypasses in adults withmoyamoya disease: a systematic review and meta-analysis. World Neurosurg. 2016;92:179-88.
8. Nam KS. Long-term outcome of motor function in a child with Moyamoya disease: a case report. J Phys Ther Sci. 2013;25:1647-9.
9. Coleman C, Marcantuono N. Moyamoya Disease and acute inpatient rehabilitation in a 17-month old previously healthy male. 2015. CWiC-PH, poster 37. http://jdc.jefferson.edu/ph/37.
10. Papavasiliou AS. Management of motor problems in cerebral palsy: a critical update for the clinician. Eur J Paediatr Neurol. 2009;13:387-96.
Duray, Mehmet ve Arzu Genç. “Moyamoya hastalığında Fonksiyonel iyileşme”. Cukurova Medical Journal, c. 42, sy. 3, 2017, ss. 596-9, doi:10.17826/cutf.324577.